W
Wolf H. Fridman
Researcher at University of Paris
Publications - 551
Citations - 60835
Wolf H. Fridman is an academic researcher from University of Paris. The author has contributed to research in topics: Immune system & Receptor. The author has an hindex of 97, co-authored 525 publications receiving 48713 citations. Previous affiliations of Wolf H. Fridman include Queen Elizabeth Hospital Birmingham & Pasteur Institute.
Papers
More filters
Journal ArticleDOI
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Marianne Debré,M C Bonnet,Wolf H. Fridman,E Carosella,N. Philippe,P Reinert,Etienne Vilmer,C Kaplan,Jean-Luc Teillaud,Claude Griscelli +9 more
TL;DR: The infusion of Fcγ fragments is an efficient treatment of acute ITP in children and strengthens the hypothesis that F cγR blockade is the main mechanism of action of IVIG in ITP, although other immunoregulatory mechanisms triggered by the presence of increased sCD16 concentrations in serum could be involved in the clinical benefit observed.
Journal Article
Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.
Eric Tartour,François Fossiez,Isabelle Joyeux,Annie Galinha,Alain Gey,Emmanuel Claret,Xavier Sastre-Garau,Jérôme Couturier,Véronique Mosseri,Virginie Vives,Jacques Banchereau,Wolf H. Fridman,John Wijdenes,Serge Lebecque,Catherine Sautèes-Fridman +14 more
TL;DR: It was shown that in vitro, IL-17 increases IL-6 and IL-8 secretion by cervical carcinoma cell lines at both protein and mRNA levels, and behaves like a T-cell-specific cytokine with paradoxical tumor-promoting activity.
Journal ArticleDOI
The clinical role of the TME in solid cancer.
Nicolas A. Giraldo,Rafael Sanchez-Salas,J David Peske,Yann Vano,Etienne Becht,Florent Petitprez,Pierre Validire,Alexandre Ingels,Xavier Cathelineau,Wolf H. Fridman,Wolf H. Fridman,Wolf H. Fridman,Catherine Sautès-Fridman,Catherine Sautès-Fridman,Catherine Sautès-Fridman +14 more
TL;DR: The critical components of the TME in solid tumours and how they shape the immune cell contexture are reviewed, and numerous studies evaluating its clinical significance are summarized from a prognostic and theranostic perspective.
Journal ArticleDOI
Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.
Bernhard Mlecnik,Marie Tosolini,Marie Tosolini,Marie Tosolini,Pornpimol Charoentong,Amos Kirilovsky,Amos Kirilovsky,Amos Kirilovsky,Gabriela Bindea,Anne Berger,Matthieu Camus,Matthieu Camus,Matthieu Camus,Mélanie Gillard,Mélanie Gillard,Mélanie Gillard,Patrick Bruneval,Wolf H. Fridman,Franck Pagès,Zlatko Trajanoski,Jérôme Galon +20 more
TL;DR: Data integration and biomolecular network reconstruction is a powerful approach to uncover molecular mechanisms in colorectal cancer and shows the utility of this approach for the investigation of malignant tumors and other diseases.
Journal ArticleDOI
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
Eric Tartour,Hélène Péré,Bernard Maillere,Magali Terme,Nathalie Merillon,Julien Taieb,Federico Sandoval,Françoise Quintin-Colonna,Françoise Quintin-Colonna,K. Lacerda,A. Karadimou,Cécile Badoual,A. Tedgui,Wolf H. Fridman,Stéphane Oudard +14 more
TL;DR: In preclinical models, antiangiogenic molecules promoted intratumor trafficking of effector cells, enhance endogenous anti-tumor response, and synergyzed with immunotherapy protocols to cure established murine tumors warrant the development of clinical trials combining antiangIogenic drugs and immunotherapy.